Acadian Asset Management
ARMP icon

Acadian Asset Management’s Armata Pharmaceuticals ARMP Stock Holding History

Acadian Asset Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,915
Closed -$46K – 1656
2018
Q2 		$46K Sell
2,915
-2,605
-47% -$42.4K ﹤0.01% 1403
2018
Q1 		$84K Buy
5,520
+5,152
+1,400% +$91.3K ﹤0.01% 1256
2017
Q4 		$5K Buy
+368
New +$5.43K ﹤0.01% 1489

Other funds holding ARMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Acadian Asset Management's ARMP Position: Q3 2018 in Review

Acadian Asset Management sold out of Armata Pharmaceuticals (ARMP) in Q3 2018, closing a stake of 2,915 shares — an estimated $46K sold.

Acadian Asset Management first reported a position in ARMP in Q4 2017 and held it in 3 quarters. The position peaked at $84K in Q1 2018. 24 funds tracked by Wall St. Rank hold ARMP as of Q3 2018.

  • Acadian Asset Management reported no remaining Armata Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Acadian Asset Management sold 2,915 Armata Pharmaceuticals shares in Q3 2018, an estimated $46K.
  • Acadian Asset Management first reported a position in Armata Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Acadian Asset Management's Armata Pharmaceuticals position peaked at $84K in Q1 2018.
  • 24 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2018.

Based on Acadian Asset Management's 13F filing for Q3 2018, filed 30 Oct 2018.